Correlation Between Genetic Technologies and MoneyMe

Can any of the company-specific risk be diversified away by investing in both Genetic Technologies and MoneyMe at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genetic Technologies and MoneyMe into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genetic Technologies and MoneyMe, you can compare the effects of market volatilities on Genetic Technologies and MoneyMe and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genetic Technologies with a short position of MoneyMe. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genetic Technologies and MoneyMe.

Diversification Opportunities for Genetic Technologies and MoneyMe

-0.21

Correlation Coefficient

Genetic Technologies  MoneyMe

Very good diversification

The 3 months correlation between Genetic and MoneyMe is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Genetic Technologies and MoneyMe in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MoneyMe and Genetic Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genetic Technologies are associated (or correlated) with MoneyMe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MoneyMe has no effect on the direction of Genetic Technologies i.e., Genetic Technologies and MoneyMe go up and down completely randomly.

Pair Corralation between Genetic Technologies and MoneyMe

Assuming the 90 days trading horizon Genetic Technologies is expected to generate 13.99 times less return on investment than MoneyMe. In addition to that, Genetic Technologies is 1.82 times more volatile than MoneyMe. It trades about 0.0 of its total potential returns per unit of risk. MoneyMe is currently generating about 0.07 per unit of volatility. If you would invest  7.90  in MoneyMe on October 4, 2024 and sell it today you would earn a total of  13.10  from holding MoneyMe or generate 165.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Genetic Technologies  vs.  MoneyMe

Genetic Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genetic Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Genetic Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

MoneyMe

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in MoneyMe are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, MoneyMe unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Genetic Technologies and MoneyMe

The main advantage of trading using opposite Genetic Technologies and MoneyMe positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genetic Technologies position performs unexpectedly, MoneyMe can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MoneyMe will offset losses from the drop in MoneyMe's long position.

The idea behind Genetic Technologies and MoneyMe pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.